The predictive value of serum intercellular adhesion molecule 1 for the progression of diabetic kidney disease in type 2 diabetic patients

1. Luis-Rodríguez D, Martínez-Castelao A, Górriz JL, De-Álvaro F, Navarro-González JF. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes. 2012 Jan 15;3(1):7-1810.4239/wjd.v3.i1.7Search in Google Scholar

2. Navarro-González JF, Mora-Fernández C, Muros de Fuentes M, García-Pérez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011 Jun;7(6):327-4010.1038/nrneph.2011.51Search in Google Scholar

3. Rivero A, Mora C, Muros M, García J, Herrera H, Navarro-González JF. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci (Lond). 2009 Mar; 116(6):479-9210.1042/CS20080394Search in Google Scholar

4. Wu CC, Sytwu HK, Lu KC, Lin YF. Role of T cells in type 2 diabetic nephropathy. Exp Diabetes Res. 2011; 2011:514738Search in Google Scholar

5. Luis-Rodríguez D, Martínez-Castelao A, Górriz JL, De-Álvaro F, Navarro-González JF. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes. 2012 Jan 15;3(1):7-1810.4239/wjd.v3.i1.7Search in Google Scholar

6. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000; 11:828-30Search in Google Scholar

7. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort RT; PREVEND Study Group. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol. 2008 Oct 15;168(8):897-90510.1093/aje/kwn209Search in Google Scholar

8. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106(14):1777-8210.1161/01.CIR.0000031732.78052.81Search in Google Scholar

9. Gu HF, Ma J, Gu KT, Brismar K., Kerstin Brismar. Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy. Front Endocrinol (Lausanne). 2012; 3: 179Search in Google Scholar

10. Ikezumi Y, Hurst LA, Masaki T, Atkins RC, Nikolic- Paterson DJ. Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial proliferation. Kidney Int 2003; 63(1): 83−9510.1046/j.1523-1755.2003.00717.xSearch in Google Scholar

11. Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant 2004; 19(12):2987-9610.1093/ndt/gfh441Search in Google Scholar

12. Matsui H, Suzuki M, Tsukuda R, Iida K, Miyasaka M, Ikeda H. Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty. Diabetes Res Clin Pract 1996; 32(1-2):1-910.1016/0168-8227(96)01209-0Search in Google Scholar

13. Watanabe N, Shikata K, Shikata Y, Sarai K, Omori K, Kodera R, et al. Involvement of MAPKs in ICAM-1 expression in glomerular endothelial cells in diabetic nephropathy. Acta Med Okayama. 2011 Aug;65(4):247-57Search in Google Scholar

14. Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, et al. Intercellular adhesion molecule-1 deficient mice are resistant against renal injury after induction of diabetes.Diabetes, 2003; 52(10): 2586-9310.2337/diabetes.52.10.258614514644Search in Google Scholar

15. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH. Intracellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol, 2005; 16(6): 1711-2210.1681/ASN.200407061215857924Search in Google Scholar

16. Upadhyay A, Larson MG, Guo CY, Vasan RS, Lipinska I, O'Donnell CJ, et al. Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transplant. 2011; 26(3): 920-610.1093/ndt/gfq471310834420682604Search in Google Scholar

17. Lin J, Glynn RJ, Rifai N, Manson JE, Ridker PM, Nathan DM, et al. Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial. Diabetes Care. 2008; 31(12): 2338-4310.2337/dc08-0277258419218796620Search in Google Scholar

18. Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, et al. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care. 2008; 31(6):1170-7610.2337/dc07-196018332153Search in Google Scholar

19. Lenghel AR, Kacso IM, Bondor CI, Rusu C, Rahaian R, Gherman Caprioara M. Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients. Diabetes Res Clin Pract. 2012;95(1):55-6110.1016/j.diabres.2011.08.02821945031Search in Google Scholar

20. Cha JJ, Hyun YY, Jee YH, Lee MJ, Han KH, Kang YS, et al. Plasma Concentration of Soluble Intercellular Adhesion Molecule-1 (sICAM-1) is Elevated in Type 2Diabetic Patients, and sICAM-1 Synthesis is Associated with Leptin-Induced Activation of the Mitogen-Activated Protein Kinase (MAPK) Pathway. Inflammation. 2013 Aug; 36(4): 878-8710.1007/s10753-013-9615-123417849Search in Google Scholar

21. Persson F, Rossing P, Hovind P, Stehouwer CD, Schalkwijk C, Tarnow L, et al. Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy. Diabetes. 2006 Dec;55(12):3550-510.2337/db06-082717130503Search in Google Scholar

22. Raluca Moldovan, Ina Kacsò, Mirela Gherman- Căprioară. Relationship between soluble intercellular adhesion molecule 1 and clinically manifest cardiovascular disease in diabetic chronic hemodialysis patients. Rev Romana Med Lab. 2012;20(4):353-361 406 Search in Google Scholar